Compare Clariane SE with Similar Stocks
Dashboard
1
Negative results in Jun 25
- OPERATING CASH FLOW(Y) Lowest at EUR 1,249.57 MM
- PRE-TAX PROFIT(Q) Lowest at EUR -34.1 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 148.8 times
2
With ROE of 3.87%, it has a Very Expensive valuation with a 0.37 Price to Book Value
3
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.42%
0%
-10.42%
6 Months
-21.41%
0%
-21.41%
1 Year
-21.23%
0%
-21.23%
2 Years
279.54%
0%
279.54%
3 Years
-16.23%
0%
-16.23%
4 Years
-72.47%
0%
-72.47%
5 Years
-81.44%
0%
-81.44%
Clariane SE for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.51%
EBIT Growth (5y)
-0.49%
EBIT to Interest (avg)
1.43
Debt to EBITDA (avg)
3.89
Net Debt to Equity (avg)
1.04
Sales to Capital Employed (avg)
0.59
Tax Ratio
25.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.60%
ROE (avg)
2.47%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.37
EV to EBIT
16.17
EV to EBITDA
4.74
EV to Capital Employed
0.68
EV to Sales
0.90
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
4.19%
ROE (Latest)
3.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
5,310.30
5,281.80
0.54%
Operating Profit (PBDIT) excl Other Income
1,012.20
1,006.70
0.55%
Interest
311.00
336.40
-7.55%
Exceptional Items
-149.50
-0.20
-74,650.00%
Consolidate Net Profit
9.20
-26.90
134.20%
Operating Profit Margin (Excl OI)
55.90%
56.80%
-0.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.54% vs 4.64% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 134.20% vs 66.50% in Dec 2024
About Clariane SE 
Clariane SE
Pharmaceuticals & Biotechnology
Korian SA, formerly Korian Medica SA, is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.
Company Coordinates 
Company Details
Cs 40070, Paris Cedex 17 , PARIS None : 75858
Registrar Details






